Orphan diseases are rare, often genetic conditions that lack effective treatment and are difficult to diagnose, with some patients waiting years for a diagnosis. Approximately 10% of human diseases are classified as rare, and while orphan drugs can be developed for treatment, economic feasibility and limited patient populations hinder research and availability. In India, awareness and knowledge about orphan drugs among pharmacy graduates are low, and medical stores do not stock these drugs due to their limited market value.